Zealand University Hospital
Vestermarksvej 9, 1., 4000 Roskilde, Denmark
About Specializations
Main research areas of the site
Chronic Lymphocytic Leukemia & Richter's Syndrome
The Zealand University Hospital Hematology department is advancing immunotherapy for relapsed/refractory Chronic Lymphocytic Leukemia and its aggressive transformation, Richter's Syndrome, by evaluating novel antibody‑based treatments.
- Dose finding for epcoritamab monotherapy
- Combination studies with venetoclax
- Safety and tolerability monitoring
- Preliminary efficacy assessment
These trials aim to define optimal dosing, demonstrate anti‑tumor activity, and potentially broaden therapeutic options for patients with limited treatment choices.
Myeloproliferative Neoplasms
Research at the site also addresses Myeloproliferative Neoplasms, focusing on conditions such as myelofibrosis and essential thrombocythemia to discover disease‑modifying agents.
- Evaluation of INCA033989 safety profile
- Assessment of disease‑modifying potential
- Exploration of biomarkers for response
- Integration with standard care pathways
The purpose of these studies is to improve therapeutic options, reduce symptom burden, and enhance quality of life for patients with chronic bone‑marrow disorders.
Prefer not to search? Our Concierge searches the trials for you.
Join our network of research sites
Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.
See the offer for sites